According to a new report, published by KBV research, The Global Biopsy Devices Market size is expected to reach $3 billion by 2028, rising at a market growth of 7.5% CAGR during the forecast period.
The Biopsy Guidance Systems segment is showcasing a CAGR of 7.7% during (2022 - 2028). Biopsy forceps are used to biopsy the ampulla wherever an ampullary cancer is found or where autoimmune pancreatitis can be possible. These could detect biopsy bile duct attacks after a biliary sphincterotomy. Pediatric biopsy forceps are used occasionally, as they can be easily inserted in the bile duct more than regular biopsy forceps, although they give us lesser tasters.
The Hospitals segment acquired maximum revenue share in the Global Biopsy Devices Market by End User in 2021 thereby, achieving a market value of $1.5 billion by 2028. This is due to the increasing cases of cancer across the globe. The patient prefers to get a cancer diagnosis in hospitals because if case they are found to have cancer, the hospital's facilities could start treatment immediately. Also, many government hospitals offer cost-efficient diagnoses raising the number of diagnoses there. This rising number is predicted to result in a high growth rate for medical devices.
The North America market dominated the Global Biopsy Devices Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1.2 billion by 2028. The Europe market is experiencing a CAGR of 7.3% during (2022 - 2028). Additionally, The Asia Pacific market would display a CAGR of 8.6% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/biopsy-devices-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Hologic, Inc., Fujifilm Holdings Corporation, B. Braun Melsungen AG, Danaher Corporation, ConMed Corporation, Becton, Dickinson and Company, Cardinal Health, Inc., Argon Medical Devices, Inc., and Cook Medical, Inc.
By Product
By End User
By Geography
Companies Profiled
Unique Offerings 
